Post Reply
1441-1460 of 10899
Biosensor announcement this evening at SGX website..... you may like to take note.
yes, its the 1st company share buy back in its history.... purchased total of 1.5 million share at SGD 1.1129. Thats a reassurance form the company and a warning to shortist. This is the floor .
yeeen123 ( Date: 08-Nov-2012 15:10) Posted:
| A DBS report says " Biosensors results below estimates, TP reduced to $1.41 (from $1.57)" ... I thought u all said the results is good, why is it interpreted as bad by the DBS? |
|
A DBS report says " Biosensors results below estimates, TP reduced to $1.41 (from $1.57)" ... I thought u all said the results is good, why is it interpreted as bad by the DBS?
Shortists hv to be very brave to short it now. Limited downside. Looks more like poor mkt sentiment, which affects most all other stocks which also reported good earnings. I'm in Bios for the longer run, as it's a safe and sound business. So many analysts, not one or 2, wrote well abt bios prospects and fair value 1.40 and abv, go read up. When the time is ripe, it'll catch up fast.
fortunecat ( Date: 08-Nov-2012 14:52) Posted:
| looks like nothing changed, still a shortist's favourite |
|
looks like nothing changed, still a shortist's favourite
Thx for the link, but that was Colin Seow's TA on Bios on 6 Nov, it's the past already. The outlook has bcome clear for Bios with last evening's announcement of good rev and profits. Once uncertainty is removed, the stock is steady again. At current price, there'll be very few willing to sell. And with good earnings, shortists would stay away.
Whether economy good or bad, doctors still hv to save heart patients.
tansenaan ( Date: 08-Nov-2012 11:54) Posted:
http://t.co/5SwgMn72
fortunecat ( Date: 08-Nov-2012 11:12) Posted:
| almost a tradition that stock price will reverse after reporting financial results for biosensor, regardless of how good the result. damn jialat stock that has screwed many people |
|
|
|
http://t.co/5SwgMn72fortunecat ( Date: 08-Nov-2012 11:12) Posted:
| almost a tradition that stock price will reverse after reporting financial results for biosensor, regardless of how good the result. damn jialat stock that has screwed many people |
|
almost a tradition that stock price will reverse after reporting financial results for biosensor, regardless of how good the result. damn jialat stock that has screwed many people
Relax bro, this is a golden opportunity to load, backed by solid earnings, buy and hold as an investment. Once Funds come in and buy for their portfolio, we may not get at this price again.
As i see it, price control for the stents may not be a bad thing, since more heart patients can afford, therefore biosensors can sell more than previously, which explains why instead of going down their profits have been steadily going up. The sold down was over done as you can see how fast price recovered the last few days.
Why it is not flying even with good result?
Take note that 2Q/1H 2011 does not include revenue from JWMS....nevertheless it's a good set of results.
yiming2000 ( Date: 08-Nov-2012 05:36) Posted:
Biosensors' latest Nov 7 report shows a net profit of 45% and its latest half-yearly profit for period ending Sep 2012 was a 34% improvement over the same period in 2011. Headline revenue growth was also a whopping 28%. These are phenomenal figures expected from Apple! Yet Biosensors price has dropped to ridiculously low levels of a company heading for bankruptcy even though its fundamentals are solid. What is the matter with the mentality of the Singapore market? Looks like it is dominated by daytraders and ignorant retirees. (I am sure the stocks they dumped were picked up by Biosensors in a buyback program that was sought by the Board in the last AGM.)
And I thought I was being screwed by some unknown forces. Luckily I stuck to my conviction and was prepared to lose everything to see this bet through. 
starlene ( Date: 07-Nov-2012 23:49) Posted:
The best financial results so far since listing..I quote from another forum...below
the chart showed a kangaroo tail which is a reversal trend. Weekly Macd histogram is getting shorter and daily MACD is showing a bullish divergence. All these are the strongest signal to show that selling has eased. Those who sell earlier will wan to buy back. Those who short this will wan to cover back.
|
|
|
|
Those who shorted also not making..some one here one to short 1.13-1.15..Biosensor always the case when about to go up..Dow(dropped > 300points) or other factors turn negative..many occasions ..but I psesvere when I have quite a fair bit previously at 60cts...acquired after Lehman fiasco when Bios even dropped < 30cts but I hold till it cross $1.30...with such good results look like the recent excess selling all the way from $1.22 to $1.05 is overdone..time to accumulate more if it dropped below 1.10 but surprising Dow dropped Biosensor still quite steady at 1.12-1.145 this morning...afternoon when market recovers,Biosensor should cross $1.15..just be patient..chartwise also looks good..downward trend reversal
allright ( Date: 08-Nov-2012 09:06) Posted:
OCBC Investment Research- Biosensors International Group: Continues to outpace industry growth Biosensors International Group (BIG) reported a 28.3% YoY increase in its revenue to US$79.8m and a 35.6% surge in its core PATMI to US$29.2m for its 2QFY13 results. Revenue missed our forecast by 10.7% but core PATMI matched our S$29.3m estimate, largely due to better-than-expected operating margin and lower effective tax rate. Although licensing revenue was disappointing (-29.4% YoY), we believe that a recovery in 2HFY13 is likely. BIG continued to experience robust growth in the EMEA and Asia-Pacific regions, underpinned by market share gains. Management maintained its 20-30% sales growth guidance for FY13. We have fine-tuned our assumptions and our DCF-derived fair value estimate inches down slightly from S$1.70 to S$1.69. Maintain BUY |
|
Those who shorted also not making..some one here one to short 1.13-1.15..Biosensor always the case when about to go up..Dow(dropped > 300points) or other factors turn negative..many occasions ..but I psesvere when I have quite a fair bit previously at 60cts...acquired after Lehman fiasco when Bios even dropped < 30cts but I hold till it cross $1.30...with such good results look like the recent excess selling all the way from $1.22 to $1.05 is overdone..time to accumulate more if it dropped below 1.10 but surprising Dow dropped Biosensor still quite steady at 1.12-1.145 this morning...afternoon when market recovers,Biosensor should cross $1.15..just be patient..chartwise also looks good..downward trend reversal
OCBC Investment Research- Biosensors International Group: Continues to outpace industry growth Biosensors International Group (BIG) reported a 28.3% YoY increase in its revenue to US$79.8m and a 35.6% surge in its core PATMI to US$29.2m for its 2QFY13 results. Revenue missed our forecast by 10.7% but core PATMI matched our S$29.3m estimate, largely due to better-than-expected operating margin and lower effective tax rate. Although licensing revenue was disappointing (-29.4% YoY), we believe that a recovery in 2HFY13 is likely. BIG continued to experience robust growth in the EMEA and Asia-Pacific regions, underpinned by market share gains. Management maintained its 20-30% sales growth guidance for FY13. We have fine-tuned our assumptions and our DCF-derived fair value estimate inches down slightly from S$1.70 to S$1.69. Maintain BUY
I initially saw Biosensors as another growing company like the past Apple, similar uptrend graph with no dividend. Paper gain turned paper lost, but didn't sell, cos it was an investment. Luckily I persevered on my believe in the company. Hopefully today's graph will show some sign of life. But last night Dow Jones dropped a lot due to worries abt the Fiscal Cliff, I wonder if this gd news came at the right time to spur buying sprint.
yiming2000 ( Date: 08-Nov-2012 05:36) Posted:
Biosensors' latest Nov 7 report shows a net profit of 45% and its latest half-yearly profit for period ending Sep 2012 was a 34% improvement over the same period in 2011. Headline revenue growth was also a whopping 28%. These are phenomenal figures expected from Apple! Yet Biosensors price has dropped to ridiculously low levels of a company heading for bankruptcy even though its fundamentals are solid. What is the matter with the mentality of the Singapore market? Looks like it is dominated by daytraders and ignorant retirees. (I am sure the stocks they dumped were picked up by Biosensors in a buyback program that was sought by the Board in the last AGM.)
And I thought I was being screwed by some unknown forces. Luckily I stuck to my conviction and was prepared to lose everything to see this bet through.
starlene ( Date: 07-Nov-2012 23:49) Posted:
The best financial results so far since listing..I quote from another forum...below
the chart showed a kangaroo tail which is a reversal trend. Weekly Macd histogram is getting shorter and daily MACD is showing a bullish divergence. All these are the strongest signal to show that selling has eased. Those who sell earlier will wan to buy back. Those who short this will wan to cover back.
|
|
|
|
Biosensors' latest Nov 7 report shows a net profit of 45% and its latest half-yearly profit for period ending Sep 2012 was a 34% improvement over the same period in 2011. Headline revenue growth was also a whopping 28%. These are phenomenal figures expected from Apple! Yet Biosensors price has dropped to ridiculously low levels of a company heading for bankruptcy even though its fundamentals are solid. What is the matter with the mentality of the Singapore market? Looks like it is dominated by daytraders and ignorant retirees. (I am sure the stocks they dumped were picked up by Biosensors in a buyback program that was sought by the Board in the last AGM.)
And I thought I was being screwed by some unknown forces. Luckily I stuck to my conviction and was prepared to lose everything to see this bet through.
starlene ( Date: 07-Nov-2012 23:49) Posted:
The best financial results so far since listing..I quote from another forum...below
the chart showed a kangaroo tail which is a reversal trend. Weekly Macd histogram is getting shorter and daily MACD is showing a bullish divergence. All these are the strongest signal to show that selling has eased. Those who sell earlier will wan to buy back. Those who short this will wan to cover back.
alexmay ( Date: 07-Nov-2012 21:03) Posted:
|
|
|
QUOTE=mowaxchua 860522]I think u shld study more on yr TA. 1st nov, the chart showed a kangaroo tail which is a reversal trend. Weekly Macd histogram is getting shorter and daily MACD is showing a bullish divergence. All these are the strongest signal to show that selling has eased. Those who sell earlier will wan to buy back. Those who short this will wan to cover back.
So how can the selling resume????
On 6Nov the 150MA cuts the 50MA..tomorrow will be comfirmation of uptrend..last fr Nov 2 close higher at 1.12 and this week so far always > 1.12..shd go up with such exceptional results the best ever results since listed
I am vested based on TA not FA.[/QUOTE]
The best financial results so far since listing..I quote from another forum...below
the chart showed a kangaroo tail which is a reversal trend. Weekly Macd histogram is getting shorter and daily MACD is showing a bullish divergence. All these are the strongest signal to show that selling has eased. Those who sell earlier will wan to buy back. Those who short this will wan to cover back.
alexmay ( Date: 07-Nov-2012 21:03) Posted:
|
Previous analyst report.
Analyst: B. Kemp Dolliver CFA(Note: Biosensors International is the world’s fourth-largest manufacturer of drug-eluting stents. Such a stent consists of a Bare Metal Stent coated with a polymer that gradually releases a drug over three to six months to inhibit the cell proliferation that causes a recurrence of narrowing of a blood vessel.)We initiate coverage of Biosensors International with a BUY rating and target price of S$1.48. The company has emerged as a leading competitor in the US$6bn global market for drug-eluting stents and we expect it to continue gaining share by virtue of its innovative technology and strong position in Asia. Our EPS estimates are US$0.075 for FY13 and US$0.083 for FY14. Our DCF-driven target price of S$1.48 is 14x FY14E EPS, which is achievable through a combination of EPS growth and multiple expansionnow eps is
http://info.sgx.com/webcoranncatth.nsf/VwAttachments/Att_A6AFF822232F751648257AAF00303AA1/$file/BIG_Q2FY2013_Announcement.pdf?openelement
gd result. tmr is going to fly high. 1.20 & above
alexmay ( Date: 07-Nov-2012 21:03) Posted:
|
For the quarter, the Group’s operating profit was US$33.9 million, representing a 71% year-on-year increase compared to the same period last year
Is this result good?
http://info.sgx.com/webcoranncatth.nsf/VwAttachments/Att_A6AFF822232F751648257AAF00303AA1/$file/BIG_Q2_FY2013_Press_Release.pdf?openelement
